Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Promising Hospital Anti-infection Strategy Probably Won’t Work

11.08.2004


Hospital patients increasingly face tenacious bacterial infections because microbes found in hospitals acquire resistance to commonly prescribed antibiotics. A recent strategy alternating the most commonly used antibiotics has sparked hope of stopping the spread of antibiotic resistance.



But a new model shows that the practice of cycling – alternating between two or more classes of antibiotics as often as every few months – probably will not work. It is an unexpected finding at a time when clinical tests of the practice with real patients are in progress.

"We were really surprised. We expected to find a number of cases where it would work, and it was the exact opposite," said Carl Bergstrom, a University of Washington assistant professor of biology.


Instead of cycling, Bergstrom said, hospitals could probably help patients more by prescribing a variety of antibiotics, a method known as mixing. That means instead of having a standard, rotating antibiotic that is used routinely within a single unit, such as intensive care, or even throughout the hospital, a more effective strategy would be to have two or more generally prescribed antibiotics being administered randomly. Two people sharing a room could routinely receive different antibiotics.

Bergstrom noted that antibiotic mixing already is relatively common, not as a conscious strategy but rather because individual doctors develop preferences for the types of medications they prescribe. That can instigate the same type of antibiotic variety as mixing would introduce.

The theory behind antibiotic cycling is that, just as a pathogen strain begins to adapt to a particular antibiotic, a new antibiotic is introduced and the pathogen must start from scratch in building resistance. However, the model implies that pathogens actually encounter new antibiotics more frequently when hospitals use antibiotic mixing than when they use cycling, so cycling is unlikely to reduce resistance levels.

"If the cycling trials that are underway don’t work, we’ll know why they don’t," Bergstrom said. "And if they do work, the people conducting the trials are going to have to do further investigation on why they are working, because the rationale that we’ve been using for cycling doesn’t hold true."

The study is based on numerical models that examined the mechanics of how microbial infections spread in hospitals and how the microbes build resistance to antibiotics. Bergstrom is the lead author of a paper detailing the work, which is being published in the Proceedings of the National Academy of Sciences and will appear online the week of Aug. 9. Co-authors are Monique Lo and Marc Lipsitch of the Harvard University School of Public Health.

Another implication of the work, Bergstrom said, is that cycling actually could be detrimental to patients, "so the studies need to be very carefully monitored to make sure we are not causing additional harm in the hospital."

He likened a hospital to a disease-ridden island in the middle of a relatively healthy river. As people get well and leave the island, they can carry with them the antibiotic-resistant organisms developed on the island and the pathogen can spread. That can make things worse when the patients carrying the resistant pathogens return to the hospital-island, as they often do.

"When you release resistant bacteria into the community, I think it’s a lot like polluting an ocean," Bergstrom said. "At first you don’t notice, but then it starts to creep up on you and you have a real problem. And then it’s hard, maybe even impossible, to go back and fix it."

| newswise
Further information:
http://www.washington.edu

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>